Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-13

Clinical Trial Update: A Study of LY2189102 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY2189102 in type 2 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2189102

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2018-03-13